Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors

Patent 11884656 was granted and assigned to Sentinel Oncology Limited on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

‌

Sentinel Oncology Limited

Current Assignee

‌

Sentinel Oncology Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

118846560

Patent Inventor Names

Robert George Boyle0

Richard Justin Boyce0

David Winter Walker0

Date of Patent

January 30, 2024

Patent Application Number

174539590

Date Filed

November 8, 2021

Patent Citations

‌

US Patent 11208405 Pyrrole derivatives as PLK1 inhibitors

Patent Primary Examiner

CPC Code

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11884656 Pyrrole derivatives as PLK1 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API